MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$21,011K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of investments
Non-cash lease expense
Stock-based compensation
Others
Negative Cash Flow Breakdown
Operating lease liabilities
Purchases of investments
Accretion of investments, net
Purchases of property and equipm...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-23,693
-13,555
-12,885
-13,879
Stock-based compensation
3,222
1,371
1,332
1,303
Impairment of property and equipment
1,625
-
-
-
Depreciation and amortization
1,257
284
307
310
Accretion of investments, net
167
333
505
577
Non-cash lease expense
6,233
829
813
801
Prepaid expenses and other assets
-772
-250
-569
27
Accounts payable and accrued liabilities
1,469
-3,071
977
1,541
Operating lease liabilities
-11,691
-747
-715
333
Net cash used in operating activities
-20,973
-14,972
-10,107
-10,195
Purchases of investments
8,395
29,405
39,105
39,507
Maturities of investments
31,503
44,000
52,500
50,000
Purchases of property and equipment
38
8
424
15
Net cash provided by investing activities
23,070
14,587
12,971
10,478
Proceeds from the exercise of stock options
36
-
-
-
Proceeds from issuance of common stock under the employee stock purchase plan
37
-
24
0
Net cash provided by financing activities
73
-
24
0
Net increase (decrease) in cash, cash equivalents, and restricted cash
2,170
-385
2,888
283
Cash, cash equivalents, and restricted cash at beginning of period
18,043
18,428
15,540
27,147
Cash, cash equivalents, and restricted cash at end of period
20,213
-
-
-
Cash and cash equivalents
20,213
-
-
-
Restricted cash
0
-
-
-
Cash, cash equivalents, and restricted cash at end of period
20,213
18,043
18,428
15,540
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Maturities of investments
$31,503K
(-71.55%↓ Y/Y)
Proceeds from issuance of
common stock under the...
$37K
(-68.38%↓ Y/Y)
Proceeds from the
exercise of stock options
$36K
Net cash provided by
investing activities
$23,070K
(60.74%↑ Y/Y)
Net cash provided by
financing activities
$73K
(-37.61%↓ Y/Y)
Canceled cashflow
$8,433K
Net increase
(decrease) in cash, cash...
$2,170K
(118.25%↑ Y/Y)
Canceled cashflow
$20,973K
Purchases of investments
$8,395K
(-91.28%↓ Y/Y)
Purchases of property and
equipment
$38K
(-64.49%↓ Y/Y)
Non-cash lease expense
$6,233K
(272.34%↑ Y/Y)
Stock-based compensation
$3,222K
(-7.68%↓ Y/Y)
Impairment of property and
equipment
$1,625K
Accounts payable and
accrued liabilities
$1,469K
(266.18%↑ Y/Y)
Depreciation and
amortization
$1,257K
(98.26%↑ Y/Y)
Prepaid expenses and
other assets
-$772K
(-467.62%↓ Y/Y)
Net cash used in
operating activities
-$20,973K
(20.43%↑ Y/Y)
Canceled cashflow
$14,578K
Net loss
-$23,693K
(24.62%↑ Y/Y)
Operating lease
liabilities
-$11,691K
(-722.52%↓ Y/Y)
Accretion of investments,
net
$167K
(-88.93%↓ Y/Y)
Buy us a coffee
Boundless Bio, Inc. (BOLD)
Boundless Bio, Inc. (BOLD)